Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)
China · Delayed Price · Currency is CNY 9.69
+0.24 (2.54%)
Jun 23, 2026, 3:04 PM CST
Xiangxue Pharmaceutical Market Cap
Xiangxue Pharmaceutical has a market cap or net worth of 6.41 billion as of June 23, 2026. Its market cap has increased by 5.33% in one year.
Market Cap
6.41B
Enterprise Value
8.09B
Revenue
1.53B
Ranking
n/a
PE Ratio
n/a
Stock Price
9.69
Market Cap Chart
Since December 15, 2010, Xiangxue Pharmaceutical's market cap has increased from 4.81B to 6.41B, an increase of 33.24%. That is a compound annual growth rate of 1.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 6.41B | 6.48% |
| Dec 31, 2025 | 6.02B | -6.86% |
| Dec 31, 2024 | 6.46B | 89.71% |
| Dec 29, 2023 | 3.41B | -14.02% |
| Dec 30, 2022 | 3.96B | -24.79% |
| Dec 31, 2021 | 5.27B | -9.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daan Gene | 7.56B |
| Innovita Biological Technology | 7.55B |
| Sino Biological,Inc. | 7.34B |
| Beijing Hotgen Biotech | 7.24B |
| Bio-Thera Solutions | 7.11B |
| Zhejiang Ausun Pharmaceutical | 6.80B |
| Acrobiosystems | 6.71B |
| Chengdu Kanghua Biological Products | 6.08B |